Old Web
English
Sign In
Acemap
>
authorDetail
>
Sue-zette Valera
Sue-zette Valera
Novartis
Panobinostat
Medicine
Internal medicine
Immunology
Pharmacology
6
Papers
52
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia
2019
Leukemia Research
Daniel J. DeAngelo
Alison R. Walker
Richard F. Schlenk
Jorge Sierra
Bruno C. Medeiros
Enrique M. Ocio
Christoph Röllig
Stephen A. Strickland
Felicitas Thol
Sue-zette Valera
Kohinoor Dasgupta
Noah Berkowitz
Robert K. Stuart
Show All
Source
Cite
Save
Citations (7)
572 Oral panobinostat in patients with advanced tumors and impaired renal function: Relationship between pharmacokinetics and key safety parameters
2014
European Journal of Cancer
Maria Grazia Porro
Sunil Sharma
Petronella O. Witteveen
Martijn P. Lolkema
Dagmar Hess
Hans Gelderblom
S. A. Hussain
Edward Waldron
Sue-zette Valera
Song Mu
Show All
Source
Cite
Save
Citations (1)
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
2014
Cancer Chemotherapy and Pharmacology
Marije Slingerland
Dagmar Hess
Sally Clive
Sunil Sharma
Per Sandström
Niklas Loman
Maria Grazia Porro
Song Mu
Edward Waldron
Sue-zette Valera
Hans Gelderblom
Show All
Source
Cite
Save
Citations (41)
Effects of Renal Function on the Pharmacokinetics of Panobinostat in Patients with Advanced Cancer: A Phase I Study
2011
Blood
Sunil Sharma
Emile E. Voest
Nicole Hagner
Petronella O. Witteveen
Martijn P. Lolkema
Neeraj Agarwal
Sue-zette Valera
Jason Li
Derek Mires
Maria Grazia Porro
Margaret M. Woo
Dagmar Hess
Show All
Source
Cite
Save
Citations (2)
1